Research Site

Shelby, North Carolina 28150

1 studies enrolling now · 9 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Hypercholesterolemia, Influenza, Mixed Dyslipidemia, Moderate to Very Severe COPD, Moderate to Very Severe Chronic Obstructive Pulmonary Disease, Proteinuric Kidney Disease, Type 2 Diabetes, Uncontrolled Asthma

Studies at this site

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease — Recruiting now
• Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) — Completed
• Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History — Completed
• Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. — Completed
• Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia — Completed
• A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma — Completed
• A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza — Completed
• Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma — Completed
• AMG 151 Amgen Protocol Number 20100761 — Completed